MEK/ERK/RUNX2 Pathway-Mediated IL-11 Autocrine Promotes the Activation of Müller Glial Cells during Diabetic Retinopathy

References

• Abu-El-Asrar AM, Dralands L, Missotten L, Al-Jadaan IA, Geboes K. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci. 2004;45(8):2760–2766. http://dx.doi.org/10.1167/iovs.03-1392.
   PubMed Web of Science ®Google Scholar
• Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes. 1998;47(3):445–449. http://dx.doi.org/10.2337/diabetes.47.3.445.
   PubMed Web of Science ®Google Scholar
• Geller SF, Lewis GP, Fisher SK. FGFR1, signaling, and AP-1 expression after retinal detachment: reactive Muller and RPE cells. Invest Ophthalmol Vis Sci. 2001;42(6):1363–1369.
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang D, Ye F, Hu DN, Liu X, Zhang L, Gao L, Song E, Zhang DY. Elevated cell proliferation and VEGF production by high-glucose conditions in Muller cells involve XIAP. Eye. 2013;27(11):1299–1307. http://dx.doi.org/10.1038/eye.2013.158.
   PubMed Web of Science ®Google Scholar
• Tout S, Chan-Ling T, Hollander H, Stone J. The role of Muller cells in the formation of the blood-retinal barrier. Neuroscience. 1993;55(1):291–301. http://dx.doi.org/10.1016/0306-4522(93)90473-s.
   PubMed Web of Science ®Google Scholar
• Choi YK, Kim KW. Blood-neural barrier: its diversity and coordinated cell-to-cell communication. BMB Rep. 2008;41(5):345–352. http://dx.doi.org/10.5483/bmbrep.2008.41.5.345.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu X, Elliott MH, Zhu M, Le YZ. Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes. 2010;59(9):2297–2305. http://dx.doi.org/10.2337/db09-1420.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Shan K, Liu BH, Liu C, Zhou RM, Li XM, Dong R, Zhang SJ, Zhang SH, Wu JH, et al. Targeting circular RNA-ZRANB1 for therapeutic intervention in retinal neurodegeneration. Cell Death Dis. 2018;9(5):540. http://dx.doi.org/10.1038/s41419-018-0597-7.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu H, Dobson JR, Browne G, Hong D, Akech J, Languino LR, Stein GS, Lian JB. Expression of the IL-11 gene in metastatic cells is supported by Runx2-Smad and Runx2-cJun complexes induced by TGFbeta1. J Cell Biochem. 2015;116(9):2098–2108. http://dx.doi.org/10.1002/jcb.25167.
   PubMed Web of Science ®Google Scholar
• Coorey NJ, Shen W, Zhu L, Gillies MC. Differential expression of IL-6/gp130 cytokines, jak-STAT signaling and neuroprotection after Muller cell ablation in a transgenic mouse model. Invest Ophthalmol Vis Sci. 2015;56(4):2151–2161. http://dx.doi.org/10.1167/iovs.14-15695.
   PubMed Web of Science ®Google Scholar
• Abu EL-Asrar AM, Ahmad A, Allegaert E, Siddiquei MM, Gikandi PW, DE Hertogh G, Opdenakker G. Interleukin-11 overexpression and M2 macrophage density are associated with angiogenic activity in proliferative diabetic retinopathy. Ocul Immunol Inflamm. 2020;28(4):575–588. http://dx.doi.org/10.1080/09273948.2019.1616772.
   PubMed Web of Science ®Google Scholar
• Schafer S, Viswanathan S, Widjaja AA, Lim WW, Moreno-Moral A, Delaughter DM, Ng B, Patone G, Chow K, Khin E, et al. IL-11 is a crucial determinant of cardiovascular fibrosis. Nature. 2017;552(7683):110–115. http://dx.doi.org/10.1038/nature24676.
   PubMed Web of Science ®Google Scholar
• Mohammad G, Kowluru RA. Diabetic retinopathy and signaling mechanism for activation of matrix metalloproteinase-9. J Cell Physiol. 2012;227(3):1052–1061. http://dx.doi.org/10.1002/jcp.22822.
   PubMed Web of Science ®Google Scholar
• Gao F, Li F, Miao Y, Xu LJ, Zhao Y, Li Q, Zhang SH, Wu J, Sun XH, Wang Z. Involvement of the MEK-ERK/p38-CREB/c-fos signaling pathway in Kir channel inhibition-induced rat retinal Muller cell gliosis. Sci Rep. 2017;7(1):1480. http://dx.doi.org/10.1038/s41598-017-01557-y.
   PubMed Web of Science ®Google Scholar
• Ge C, Xiao G, Jiang D, Yang Q, Hatch NE, Roca H, Franceschi RT. Identification and functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor. J Biol Chem. 2009;284(47):32533–32543. http://dx.doi.org/10.1074/jbc.M109.040980.
   PubMed Web of Science ®Google Scholar
• Greenblatt MB, Shim JH, Zou W, Sitara D, Schweitzer M, Hu D, Lotinun S, Sano Y, Baron R, Park JM, et al. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest. 2010;120(7):2457–2473. http://dx.doi.org/10.1172/JCI42285.
   PubMed Web of Science ®Google Scholar
• Limb GA, Salt TE, Munro PM, Moss SE, Khaw PT. In vitro characterization of a spontaneously immortalized human Muller cell line (MIO-M1). Invest Ophthalmol Vis Sci. 2002;43(3):864–869.
   PubMed Web of Science ®Google Scholar
• Vitolo MI, Anglin IE, Mahoney WM Jr, Renoud KJ, Gartenhaus RB, Bachman KE, Passaniti A. The RUNX2 transcription factor cooperates with the YES-associated protein, YAP65, to promote cell transformation. Cancer Biol Ther. 2007;6(6):856–863. http://dx.doi.org/10.4161/cbt.6.6.4241.
   PubMed Web of Science ®Google Scholar
• Cruzat A, Gonzalez-Andrades M, Mauris J, Abusamra DB, Chidambaram P, Kenyon KR, Chodosh J, Dohlman CH, Argueso P. Colocalization of galectin-3 with CD147 is associated with increased gelatinolytic activity in ulcerating human corneas. Invest Ophthalmol Vis Sci. 2018;59(1):223–230. http://dx.doi.org/10.1167/iovs.17-23196.
   PubMed Web of Science ®Google Scholar
• Zhao M, Liu Y, Liu R, Qi J, Hou Y, Chang J, Ren L. Upregulation of IL-11, an IL-6 family cytokine, promotes tumor progression and correlates with poor prognosis in non-small cell lung cancer. Cell Physiol Biochem. 2018;45(6):2213–2224. http://dx.doi.org/10.1159/000488166.
   PubMedGoogle Scholar
• Mack M. Autocrine activation of fibroblasts by induction of IL-11 expression is a common pathway of profibrotic factors. Transplantation. 2018;102(5):710–711. http://dx.doi.org/10.1097/TP.0000000000002181.
   PubMed Web of Science ®Google Scholar
• Onnis B, Fer N, Rapisarda A, Perez VS, Melillo G. Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells. J Clin Invest. 2013;123(4):1615–1629. http://dx.doi.org/10.1172/JCI59623.
   PubMed Web of Science ®Google Scholar
• Komori T. Regulation of proliferation, differentiation and functions of osteoblasts by Runx2. Int J Mol Sci. 2019;20(7):1694. http://dx.doi.org/10.3390/ijms20071694.
   PubMed Web of Science ®Google Scholar
• Xiao D, Bi R, Liu X, Mei J, Jiang N, Zhu S. Notch signaling regulates MMP-13 expression via Runx2 in chondrocytes. Sci Rep. 2019;9(1):15596. http://dx.doi.org/10.1038/s41598-019-52125-5.
   PubMed Web of Science ®Google Scholar
• Takarada T, Yoneda Y. Transactivation by Runt related factor-2 of matrix metalloproteinase-13 in astrocytes. Neurosci Lett. 2009;451(2):99–104. http://dx.doi.org/10.1016/j.neulet.2008.12.037.
   PubMed Web of Science ®Google Scholar
• Nakazato R, Takarada T, Ikeno S, Nakamura S, Kutsukake T, Hinoi E, Yoneda Y. Upregulation of runt-related transcription factor-2 through CCAAT enhancer binding protein-beta signaling pathway in microglial BV-2 cells exposed to ATP. J Cell Physiol. 2015;230(10):2510–2521. http://dx.doi.org/10.1002/jcp.24988.
   PubMed Web of Science ®Google Scholar
• Yao R, Yao X, Liu R, Peng J, Tian T. Glucose-induced microRNA-218 suppresses the proliferation and promotes the apoptosis of human retinal pigment epithelium cells by targeting RUNX2. Biosci Rep. 2019;39:12. http://dx.doi.org/10.1042/BSR20192580.
   Web of Science ®Google Scholar
• Chen Y, Hu Y, Yang L, Zhou J, Tang Y, Zheng L, Qin P. Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3beta/beta-catenin pathway. Cell Biol Int. 2017;41(8):822–832. http://dx.doi.org/10.1002/cbin.10779.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang B, Li Y, Wang D, Lingling E, Bai Y, Liu H. High glucose inhibits osteogenic differentiation through the BMP signaling pathway in bone mesenchymal stem cells in mice. EXCLI J. 2013;12:584–597.
   PubMed Web of Science ®Google Scholar
• D’Souza DR, Salib MM, Bennett J, Mochin-Peters M, Asrani K, Goldblum SE, Renoud KJ, Shapiro P, Passaniti A. Hyperglycemia regulates RUNX2 activation and cellular wound healing through the aldose reductase polyol pathway. J Biol Chem. 2009;284(27):17947–17955. http://dx.doi.org/10.1074/jbc.M109.002378.
   PubMed Web of Science ®Google Scholar
• Ng B, Dong J, D’Agostino G, Viswanathan S, Widjaja AA, Lim WW, Ko NSJ, Tan J, Chothani SP, Huang B, et al. Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis. Sci Transl Med. 2019;11:511. http://dx.doi.org/10.1126/scitranslmed.aaw1237.
   Web of Science ®Google Scholar
• Corden B, Adami E, Sweeney M, Schafer S, Cook SA. IL-11 in cardiac and renal fibrosis: late to the party but a central player. Br J Pharmacol. 2020;177(8):1695–1708. http://dx.doi.org/10.1111/bph.15013.
   PubMed Web of Science ®Google Scholar
• Elshabrawy HA, Volin MV, Essani AB, Chen Z, Mcinnes IB, VAN Raemdonck K, Palasiewicz K, Arami S, Gonzalez M, Ashour HM, et al. IL-11 facilitates a novel connection between RA joint fibroblasts and endothelial cells. Angiogenesis. 2018;21(2):215–228. http://dx.doi.org/10.1007/s10456-017-9589-y.
   PubMed Web of Science ®Google Scholar
• Cook SA, Schafer S. Hiding in plain sight: interleukin-11 emerges as a master regulator of fibrosis, tissue integrity, and stromal inflammation. Annu Rev Med. 2020;71:263–276. http://dx.doi.org/10.1146/annurev-med-041818-011649.
   PubMed Web of Science ®Google Scholar
• Xie H, Zhang C, Liu D, Yang Q, Tang L, Wang T, Tian H, Lu L, Xu JY, Gao F, et al. Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy. Diabetologia. 2021;64(1):211–225. http://dx.doi.org/10.1007/s00125-020-05299-x.
   PubMed Web of Science ®Google Scholar
• Diaz-Coranguez M, Lin CM, Liebner S, Antonetti DA. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability. J Biol Chem. 2020;295(14):4647–4660. http://dx.doi.org/10.1074/jbc.RA119.011273.
   PubMed Web of Science ®Google Scholar
• Fan L, Yan H. FTY720 attenuates retinal inflammation and protects blood-retinal barrier in diabetic rats. Invest Ophthalmol Vis Sci. 2016;57(3):1254–1263. http://dx.doi.org/10.1167/iovs.15-18658.
   PubMed Web of Science ®Google Scholar
• Rangasamy S, Mcguire PG, Franco Nitta C, Monickaraj F, Oruganti SR, Das A. Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy. PLoS One. 2014;9(10):e108508. http://dx.doi.org/10.1371/journal.pone.0108508.
   PubMed Web of Science ®Google Scholar
• Huang C, Fisher KP, Hammer SS, Navitskaya S, Blanchard GJ, Busik JV. Plasma exosomes contribute to microvascular damage in diabetic retinopathy by activating the classical complement pathway. Diabetes. 2018;67(8):1639–1649. http://dx.doi.org/10.2337/db17-1587.
   PubMed Web of Science ®Google Scholar